biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The good news...

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Apr 14, 2023 10:45pm

94 Views

Post# 35396360

RE:RE:The good news...

Coward, TheTruth1234. Had to create a new alias to take a shot at me. Social media is populated with anonymous cowards.

Well, my name is John Davenport and I have no need or desire to be anonymous. I speak the truth as I see it.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale